These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9829852)

  • 1. Multilineage involvement and erythropoietin-"independent" erythroid progenitor cells in a patient with systemic mastocytosis.
    Afonja O; Amorosi E; Ashman L; Takeshita K
    Ann Hematol; 1998 Oct; 77(4):183-6. PubMed ID: 9829852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis.
    Akin C; Kirshenbaum AS; Semere T; Worobec AS; Scott LM; Metcalfe DD
    Exp Hematol; 2000 Feb; 28(2):140-7. PubMed ID: 10706069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined action of c-kit and erythropoietin on erythroid progenitor cells.
    Ohneda O; Yanai N; Obinata M
    Development; 1992 Jan; 114(1):245-52. PubMed ID: 1374312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIT(D816V+) systemic mastocytosis associated with KIT(D816V+) acute erythroid leukaemia: first case report with molecular evidence for same progenitor cell derivation.
    McClintock-Treep SA; Horny HP; Sotlar K; Foucar MK; Reichard KK
    J Clin Pathol; 2009 Dec; 62(12):1147-9. PubMed ID: 19729359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-kit activating mutation in a neonate with in-utero presentation of systemic mastocytosis associated with myeloproliferative disorder.
    Kuint J; Bielorai B; Gilat D; Birenbaum E; Amariglio N; Rechavi G
    Br J Haematol; 1999 Sep; 106(3):838-9. PubMed ID: 10468886
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical correlates of the presence of the Asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis.
    Worobec AS; Semere T; Nagata H; Metcalfe DD
    Cancer; 1998 Nov; 83(10):2120-9. PubMed ID: 9827716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene.
    Yavuz AS; Lipsky PE; Yavuz S; Metcalfe DD; Akin C
    Blood; 2002 Jul; 100(2):661-5. PubMed ID: 12091362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-kit mutation and osteopetrosis-like osteopathy in a patient with systemic mast cell disease.
    Reinacher-Schick A; Petrasch S; Longley BJ; Teschendorf C; Graeven U; Schmiegel W
    Ann Hematol; 1998 Sep; 77(3):131-4. PubMed ID: 9797083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the lineage relationship between mast cells and basophils using the c-kit D816V mutation as a biologic signature.
    Kocabas CN; Yavuz AS; Lipsky PE; Metcalfe DD; Akin C
    J Allergy Clin Immunol; 2005 Jun; 115(6):1155-61. PubMed ID: 15940128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia.
    Sotlar K; Marafioti T; Griesser H; Theil J; Aepinus C; Jaussi R; Stein H; Valent P; Horny HP
    Mol Pathol; 2000 Aug; 53(4):188-93. PubMed ID: 11040941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current state of biology and diagnosis of clonal mast cell diseases in adults.
    Alvarez-Twose I; Morgado JM; Sánchez-Muñoz L; García-Montero A; Mollejo M; Orfao A; Escribano L
    Int J Lab Hematol; 2012 Oct; 34(5):445-60. PubMed ID: 22551157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm.
    Longley BJ; Tyrrell L; Lu SZ; Ma YS; Langley K; Ding TG; Duffy T; Jacobs P; Tang LH; Modlin I
    Nat Genet; 1996 Mar; 12(3):312-4. PubMed ID: 8589724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis.
    Fritsche-Polanz R; Jordan JH; Feix A; Sperr WR; Sunder-Plassmann G; Valent P; Födinger M
    Br J Haematol; 2001 May; 113(2):357-64. PubMed ID: 11380399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognizing mastocytosis in patients with anaphylaxis: value of KIT D816V mutation analysis of peripheral blood.
    Broesby-Olsen S; Oropeza AR; Bindslev-Jensen C; Vestergaard H; Møller MB; Siebenhaar F; Kristensen T; Mortz CG; ;
    J Allergy Clin Immunol; 2015 Jan; 135(1):262-4. PubMed ID: 25091436
    [No Abstract]   [Full Text] [Related]  

  • 15. Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations.
    Yang Y; Létard S; Borge L; Chaix A; Hanssens K; Lopez S; Vita M; Finetti P; Birnbaum D; Bertucci F; Gomez S; de Sepulveda P; Dubreuil P
    Blood; 2010 Aug; 116(7):1114-23. PubMed ID: 20484085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic myelogenous leukemia with acquired c-kit activating mutation and transient bone marrow mastocytosis.
    Cairoli R; Grillo G; Beghini A; Cornacchini G; Larizza L; Morra E
    Hematol J; 2004; 5(3):273-5. PubMed ID: 15167915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder.
    Chatterjee A; Ghosh J; Kapur R
    Oncotarget; 2015 Jul; 6(21):18250-64. PubMed ID: 26158763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic abnormalities and their lack of relationship to the Asp816Val c-kit mutation in the pathogenesis of mastocytosis.
    Worobec AS; Akin C; Scott LM; Metcalfe DD
    J Allergy Clin Immunol; 1998 Sep; 102(3):523-4. PubMed ID: 9768597
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.
    Nagata H; Worobec AS; Oh CK; Chowdhury BA; Tannenbaum S; Suzuki Y; Metcalfe DD
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10560-4. PubMed ID: 7479840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.
    Sotlar K; Bache A; Stellmacher F; Bültmann B; Valent P; Horny HP
    J Mol Diagn; 2008 Jan; 10(1):58-66. PubMed ID: 18165278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.